Dr. Kenji Yamamoto, a Japanese cardiovascular surgeon, has penned a letter to the peer-reviewed journal Virology that calls for an end to the COVID-19 vaccine booster program in the country.
The European Medicines Agency (EMA) today recommended adding a warning for two types of heart inflammation to Novavax’s COVID-19 vaccine, marketed under the brand names Nuvaxovid and Covovax, based on a small number of cases reported in those who received the vaccine.
The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,350,950 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and July 15, 2022, to the Vaccine Adverse Event Reporting System (VAERS).